Nasal NK/T-cell lymphoma: where are we now?

Oncology (Williston Park). 2010 Apr 15;24(4):362-3.

Author

Mary Jo Lechowicz¹

Affiliation

¹ Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.

PMID: 20464849

No abstract available

Publication types

Comment

MeSH terms

Combined Modality Therapy
Humans
Lymphoma, Extranodal NK-T-Cell / pathology
Lymphoma, Extranodal NK-T-Cell / therapy*
Nose Neoplasms / pathology
Nose Neoplasms / therapy*
Treatment Outcome